Crocs (NASDAQ:CROX) Price Target Raised to $148.00 at UBS Group

Crocs (NASDAQ:CROX) had its price objective increased by equities researchers at UBS Group from $124.00 to $148.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm currently has a “neutral” rating on the textile maker’s stock. UBS Group’s target price indicates a potential upside of 10.12% from the company’s previous close.

A number of other research analysts also recently commented on CROX. Williams Trading reaffirmed a “hold” rating and issued a $125.00 target price (down from $135.00) on shares of Crocs in a research report on Tuesday, April 16th. Wedbush reissued an “outperform” rating and set a $154.00 price objective on shares of Crocs in a research report on Friday, May 3rd. Stifel Nicolaus raised their price objective on shares of Crocs from $140.00 to $158.00 and gave the stock a “buy” rating in a research report on Wednesday. B. Riley raised their price objective on shares of Crocs from $95.00 to $122.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 10th. Finally, Monness Crespi & Hardt raised their price objective on shares of Crocs from $140.00 to $170.00 and gave the stock a “buy” rating in a research report on Wednesday. Four investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $150.25.

Crocs Stock Down 1.5 %

Shares of CROX traded down $2.09 during midday trading on Wednesday, reaching $134.40. The stock had a trading volume of 72,150 shares, compared to its average volume of 1,410,411. Crocs has a 1-year low of $74.00 and a 1-year high of $146.79. The company’s fifty day simple moving average is $129.57 and its two-hundred day simple moving average is $109.82. The company has a market cap of $8.16 billion, a price-to-earnings ratio of 10.49, a PEG ratio of 1.56 and a beta of 2.03. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.30 and a quick ratio of 0.75.

Crocs (NASDAQ:CROX) last posted its earnings results on Tuesday, May 7th. The textile maker reported $3.02 EPS for the quarter, beating analysts’ consensus estimates of $2.25 by $0.77. The firm had revenue of $938.60 million for the quarter, compared to the consensus estimate of $884.29 million. Crocs had a net margin of 20.00% and a return on equity of 61.97%. The company’s revenue was up 6.2% on a year-over-year basis. During the same period last year, the firm posted $2.61 EPS. Equities research analysts expect that Crocs will post 12.44 earnings per share for the current year.

Insiders Place Their Bets

In other Crocs news, EVP Daniel P. Hart sold 10,000 shares of Crocs stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $118.48, for a total transaction of $1,184,800.00. Following the completion of the transaction, the executive vice president now owns 219,293 shares in the company, valued at $25,981,834.64. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other Crocs news, EVP Daniel P. Hart sold 10,000 shares of Crocs stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $118.48, for a total transaction of $1,184,800.00. Following the completion of the transaction, the executive vice president now owns 219,293 shares in the company, valued at $25,981,834.64. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director John B. Replogle bought 1,972 shares of the business’s stock in a transaction on Thursday, March 14th. The shares were acquired at an average price of $126.75 per share, with a total value of $249,951.00. Following the transaction, the director now owns 3,153 shares of the company’s stock, valued at approximately $399,642.75. The disclosure for this purchase can be found here. Over the last quarter, insiders sold 39,867 shares of company stock worth $4,786,276. Insiders own 2.72% of the company’s stock.

Institutional Investors Weigh In On Crocs

Hedge funds and other institutional investors have recently modified their holdings of the company. Raymond James & Associates grew its holdings in shares of Crocs by 235.8% during the fourth quarter. Raymond James & Associates now owns 58,514 shares of the textile maker’s stock worth $5,466,000 after buying an additional 41,091 shares in the last quarter. Tealwood Asset Management Inc. purchased a new stake in shares of Crocs during the fourth quarter worth about $865,000. Teachers Retirement System of The State of Kentucky grew its holdings in Crocs by 27.4% in the third quarter. Teachers Retirement System of The State of Kentucky now owns 38,609 shares of the textile maker’s stock valued at $3,407,000 after purchasing an additional 8,297 shares during the period. WealthPlan Investment Management LLC purchased a new stake in Crocs in the third quarter valued at approximately $575,000. Finally, Townsend & Associates Inc grew its holdings in Crocs by 100.2% in the third quarter. Townsend & Associates Inc now owns 53,659 shares of the textile maker’s stock valued at $4,614,000 after purchasing an additional 26,860 shares during the period. 93.44% of the stock is currently owned by hedge funds and other institutional investors.

About Crocs

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.